Molecular Logic Gates: Engineering Ribosomal Computing in Bacteria

Engineered RNA riboswitches operating inside E. coli ribosomes execute boolean logic (AND, OR, NOT) with 99.2% fidelity.

Synthesized in 46 Days: Generative AI Crafts De Novo Lung Cancer Inhibitor

Leveraging geometric diffusion models, researchers engineered an alpha-helical microprotein targeting oncogenic KRAS G12D in non-small cell lung cancer within 46 days.

CT in a Backpack: 35kg Battery-Powered Xtomo-Cube Overhauls Emergency Triage

Engineers unveiled Xtomo-Cube, a 35 kg portable computed tomography system powered by cold field-emission carbon nanotube arrays, slashing radiation by 85%.

WashU Identifies Skull Bone Marrow Channels as Primary Glioblastoma Ally

Scientists at WashU Medicine discovered that glioblastoma actively recruits immunosuppressive neutrophils directly from the skull bone marrow via hundreds of direct bony channels. Blocking tumor-deriv…

Non-Invasive Deep Brain Stimulation via Temporal Interference

Traditional deep brain stimulation requires surgical burr-hole brain lead implantation. Non-invasive Temporal Interference stimulation passes two high-frequency fields through the scalp, generating a …

Focused Ultrasound: Transient Blood-Brain Barrier Permeabilization

The blood-brain barrier blocks over 98% of small-molecule oncology drugs. Non-invasive low-intensity focused ultrasound paired with circulating microbubbles opens localized endothelial junctions for 6…

Myocardial Fibrosis Regression: In Vivo LNP-mRNA Therapy

Post-infarction scarring irreversibly drives ischemic heart failure. Cardioselective lipid nanoparticles delivering anti-FAP mRNA transiently reprogram circulating T cells in vivo, producing a 38% fib…

Universal Off-the-Shelf Base-Edited CAR-T Therapy

Autologous CAR-T cell manufacturing takes up to a month and costs half a million dollars per patient. Multiplex base editing knocks out TCR and HLA Class I in healthy donor T-cells without double-stra…

FDA Approves Pixclara: Targeted PET Tracer for Brain Glioma Imaging

The FDA approved Telix Pharmaceuticals' Pixclara (TLX101-Px). Utilizing 18F-FET to target LAT1 and LAT2 amino acid transporters, the radiotracer distinguishes recurrent brain glioma from radiation nec…

Corbus CRB-913: Peripheral CB1 Inverse Agonist Drives 5% Weight Loss Without CNS Events

Corbus Pharmaceuticals announced Phase 1b CANYON-1 data for CRB-913, achieving 5.0% mean weight loss at 12 weeks with no plateau. Due to strict peripheral restriction (0% brain penetration), the oral …

Mapping Glioma Margins: FDA Approves Telix's Pixclara PET Imaging Agent

Overcoming MRI edema limitations, 18F-FET selectively illuminates malignant glioma tissue with unprecedented contrast.

Selective Allosteric Blockade: FDA Grants Priority Review to Takeda's Zasocitinib

Targeting the JH2 pseudokinase domain completely avoids hematological cytopenias typical of first-generation pan-JAK blockers.

Dismantling RAS: Daraxonrasib Delivers 84% Disease Control in Pancreatic Cancer

Using endogenous cyclophilin A as an intracellular chaperone finally drugs smooth GTP-bound RAS interfaces.

Nuclear Oncology: ITM Scales Production of 177Lu Bexlutry Radioligand

Targeted peptide receptor radionuclide therapy (PRRT) delivers pinpoint cytotoxic ionizing radiation directly to neuroendocrine cancer cells.

Braking Inflammation: Discovery of the Native Metabolic Switch Halting Chronic Autoimmunity

Chronic inflammation damages joints and vascular walls. Current immunosuppressants leave patients vulnerable to sepsis; selective metabolic reprogramming changes that.

Breaching the Lethal Bunker: Targeted Disruption of Pancreatic Cancer's Fibrotic Shield

Pancreatic tumors encase themselves in rigid fibrotic stroma that crushes vasculature and repels cytotoxic T-cells. Breaching this matrix restores therapeutic efficacy.

AlphaFold2 Uncovers Hidden Branch of GPCR Family by Structural Shape Alignment

G-protein-coupled receptors (GPCRs) represent the most extensively validated drug target class in modern pharmacology, targeted by ~34% of FDA-approved medicines. Using AlphaFold2, biologists identifi…

Cancer Weakness Unveiled: Targeting Lineage Plasticity in Resistant Tumors

While androgen receptor inhibitors extend survival, co-deletion of TP53 and RB1 tumor suppressors drives deadly lineage plasticity: luminal adenocarcinoma cells transdifferentiate into aggressive smal…

Breaching Tumor Shields: How Dormant Cancer Cells Survive Chemotherapy

Cytotoxic chemotherapies exclusively kill actively dividing cells, allowing solitary disseminated tumor cells sequestered in bone marrow and visceral organs to linger in G0 dormancy for decades, entir…

Apple Watch Series 12 & Ultra: 3,500-Nit MicroLED, S11 SiP Health Sensing Suite & Daily Readiness

Single-Infusion Blood Cancer Remission: In Vivo JY231 Therapy Trialed in China

Healthcare Privacy Crisis: Attackers Exfiltrate 4.1 Million Medical Records

How to Lock the Death Hatch in Motor Neurons? NRG Therapeutics Doses First Patients with ALS Drug NRG5051

Amyotrophic Lateral Sclerosis (ALS) remains one of medicine's most brutal death sentences, progressively paralyzing muscles while cognitive faculties stay intact. Scientists discovered that at the roo…

Битва за оральные GLP-1: Eli Lilly, Novo Nordisk и Viking хоронят эпоху еженедельных уколов

UCLA: Созданы универсальные Т-клетки «из морозилки» для уничтожения солидных опухолей

McGill: Бьющееся «мини-сердце» на микрочипе вырастили из капли крови пациента

Невидимый виновник давления: почему миллионы людей безуспешно пьют таблетки от гипертонии

MIT Engineers Create Wearable Ultrasound Patch for 24/7 Cardiac Imaging

Personalized mRNA Melanoma Vaccine Enters Final Phase III Trials

Амёба, которую приняли за воспаление сосудов

### Что произошло

Карта разговоров между клетками

### Что предлагают исследователи